Global RFID Blood Monitoring Systems Market to Reach $288.1 Million by 2027
Amid the COVID-19 crisis, the global market for RFID Blood Monitoring Systems estimated at US$81.8 Million in the year 2020, is projected to reach a revised size of US$288.1 Million by 2027, growing at aCAGR of 19.7% over the period 2020-2027. RFID Systems, one of the segments analyzed in the report, is projected to record 21.4% CAGR and reach US$199.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RFID Tags segment is readjusted to a revised 16.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $24.4 Million, While China is Forecast to Grow at 19.2% CAGR
The RFID Blood Monitoring Systems market in the U.S. is estimated at US$24.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$50.3 Million by the year 2027 trailing a CAGR of 19.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 16.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.5% CAGR.We bring years of research experience to this 8th edition of our report. The 130-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- Honeywell International, Inc.
- LogiTag Ltd.
- Mediware Information Systems, Inc.
- Mobile Aspects, Inc.
- Nordic ID Group
- STANLEY Healthcare
- Zebra Technologies Corporation